The salicylate content of foods is controversial.
In the forum of your link (
http://salicylatesensitivity.com/forum/ ... e=1#Item_0), there is a reference to a paper (
http://ajph.aphapublications.org/cgi/re ... 7/1124.pdf) that says :
"Ingester and Feinleibl suggested that an increase in salicylate intake (including intakes from foods) might have contributed to the decline in cardiovascular disease observed in the past several decades. However, the salicylate content of foods remains controversial. The authors cited the results of Swain et al.,2 who tested 333 foods and estimated that average salicylate levels in the
Western diet might range from 10 to 200 mg per person per day. However, Swain et al.'s results could not be confirmed in subse-quent studies that used validated biochemi-cal analytic techniques.3'4 In particular, Ven-ema et al.3 found much lower levels of nat-ural salicylates in vegetables and fruits and even in herbs and spices. Janssen et al.4 found very low urinary concentrations of salicylates in 17 volunteers from 14 coun-tries and 4 continents who consumed a vari-ety of self-selected diets. They concluded that the bioavailable salicylate contents of human diets were too low to affect cardio-vascular disease risk. For some subjects in the Janssen et al.
study, the estimated intakes of dietary sali-cylates based on the Swain et al. test results were 2-fold to 100-fold higher than urinary
concentrations, a valid indicator of salicylate intake. It appears that the assays of Swain et al. lacked specificity, and thus the salicylate
contents of foods were grossly overesti-mated. In testing the salicylate-cardiovascu-lar disease hypothesis using dietary data from existing cohort or case-control studies, a logical first step is to correctly quantify the amount of salicylates in various foods and
establish a food composition database for salicylates. However, given the test results of Janssen et al., the value of this effort is
questionable. Also, salicylates per se do not affect thromboxane B2 formation or platelet aggregation.5 It is acetylsalicylate that is
able to inactivate cyclo-oxygenase and sub-sequently affect cardiovascular risk. "
Anne Swain's PhD thesis titled "The Role of Natural Salicylates in Food Intolerance":
http://www.sswahs.nsw.gov.au/rpa/allerg ... Thesis.pdf